Coverfoto van InProcess-LSP
InProcess-LSP

InProcess-LSP

Nanotechnologisch onderzoek

In-line & realtime characterization of nanoparticles in processes. Save time, save money, control production processes.

Over ons

NanoParticle Characterization The NanoFlowSizer is the only instrument capable of sizing nanoparticles in-line and realtime for (manufacturing)processes in pharma, chemical, food & dairy and cosmetics industry. Whether it is an in/on-line, at-line or lab application, the NanoFlowSizer is a unique tool to improve and optimize your nanoparticle process. This will result in: 1. Saving costs 2. Saving time 3. Full process control 4. Conituous manufacturing and realtime release options 5. True in-line measurement enabling PAT InProcess-LSP innnovates with a strong sense of pragmatism and a creative results driven mindset. In our well-equipped PAT laboratory, we can perform feasibility, development and validation activities in-house. This offers logistical benefits, avoiding possible interference with your processes, resources and facilities. With our strong background in Pharma and Life Science you can rely on a highly skilled and very experienced team of specialists, supporting your needs in those areas where you need additional expertise and resources. In addition you will find in us a dedicated, reliable and enthusiastic partner. "Towards groundbreaking solutions!"

Branche
Nanotechnologisch onderzoek
Bedrijfsgrootte
11 - 50 medewerkers
Hoofdkantoor
Oss
Type
Naamloze vennootschap
Opgericht
2014
Specialismen
Process Analytical Technology, Quality by Design, Non-destructive analytical technologies, Process Improvement, Pharma and Life Science Industry, Nanoparticles, Nanoparticle sizing, nanoparticle characterization, Process Control, Nanoparticle characterization, nanomedicine measurement, vaccine development en vaccine manufacturing

Locaties

Medewerkers van InProcess-LSP

Updates

Vergelijkbare pagina’s

Door vacatures bladeren

Financiering

InProcess-LSP 2 rondes in totaal

Laatste ronde

Toekennen

US$ 81.868,00

Bekijk meer informatie over Crunchbase